Recently, Krasniqi et al.26 demonstrated BMI ≥ 30 was associated with worse OS in an observational cohort of 709 HER2 positive ABC patients treated with pertuzumab, trastuzumab, and/or T‐DM1. The gene discussed is ERBB2; the disease is aneurysmal bone cyst.